相关实验视频

Updated: Sep 13, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

在检测和管理脆弱冠状动脉斑块方面的进展

Marco Spagnolo¹, Daniele Giacoppo¹, Claudio Laudani¹

¹Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico "G. Rodolico-San Marco", University of Catania, Italy.

Circulation. Cardiovascular interventions

|July 28, 2025

概括

在冠状动脉疾病中检测脆弱斑块 (VPs) 对于预防血栓形成至关重要. 新的全身疗法和静脉内成像指导型支架显示出稳定VP和改善患者结果的前景.

科学领域:

心血管医学心血管医学
医疗成像医学成像
干预心脏病学干预心脏病学

背景情况:

冠状动脉疾病 (CAD) 管理需要早期检测易破裂的斑块,称为脆弱斑块 (VPs),以防止危及生命的血栓形成.
目前的侵入性诊断模式提供了组织学见解,但在积极的预测价值和广泛查的适用性方面存在局限性.
非侵入性技术具有更广泛的潜力,但目前在特异性和分辨率方面落后于侵入性方法.

研究的目的:

审查目前在冠状动脉疾病中识别和管理脆弱斑块 (VPs) 的理解和进展.
探索系统疗法和血管内成像引导的预防性支架在VP稳定中的作用.
突出了对新型诊断工具和治疗策略的进一步证据的需要.

主要方法:

审查关于脆弱斑块检测和管理策略的现有文献.
系统治疗对斑块特征 (纤维状盖,动脉瘤,死核,炎症) 的影响分析.
评估新兴的血管内成像导向的预防性支架方式及其临床试验结果.

主要成果:

系统疗法可以通过修改主要的斑块成分来抵消斑块的进展并稳定VP.
血管内成像指导的预防性支架显示了密封和被动化VP的有希望的结果.
设备技术和生物相容性的进步支持预防性支架的可行性.

结论:

对影响斑块演变的因素的全面理解正在完善VP的识别和管理.
系统疗法为VP稳定提供了一个有希望的途径.
进一步的临床证据对于确定新型诊断和治疗策略对脆弱斑块的净益处至关重要.

关键词:

心血管诊断技巧心血管诊断技巧心血管疾病药物心血管疾病药物心血管疾病的危险因素冠状动脉疾病是一种冠状动脉疾病.心肌梗塞的心脏病发作通过皮肤进行冠状动脉干预.有关风险因素的风险因素.

更多相关视频

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

相关概念视频

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...

Acute Coronary Syndrome IV: Interprofessional Care

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

Angina IV: Management

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...